Literature DB >> 1568171

A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma.

C I Kiricuta1, J Tausch.   

Abstract

The major prognostic indicator in patients with breast cancer is the presence of metastases in axillary lymph nodes. The authors developed a mathematical model, based on 1446 complete axillary dissections performed in Milan between 1983 and 1986, and determined the following: (1) the sample size from Level I necessary for a 90% certainty degree of N0 axillary status; (2) the probability of residual tumor in the axilla after axillary sampling from Level I; and (3) the maximum number of involved axillary nodes in Levels I, II, and III to be expected (90% certainty) after sampling from Level I. Thus, this model permitted the determination of the cutoff level for a true N0 axillary status when only a few nodes are sampled from Level I. The cutoff level for a T1 primary tumor is ten axillary nodes removed and found uninvolved. Also, this model provides guidance in managing possible residual tumor after an incomplete axillary dissection. This information is important in indicating adjuvant axillary radiation therapy and chemotherapy or hormone therapy.

Entities:  

Mesh:

Year:  1992        PMID: 1568171     DOI: 10.1002/1097-0142(19920515)69:10<2496::aid-cncr2820691018>3.0.co;2-t

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  23 in total

1.  The reliability of sampling three to six nodes for staging breast cancer.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  1999-09       Impact factor: 3.411

2.  How to improve low lymph node recovery rates from axillary clearance specimens of breast cancer. A short-term audit.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  1998-11       Impact factor: 3.411

Review 3.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

4.  Estimating the overlap between sentinel lymph nodes and axillary node samples in breast cancer.

Authors:  G Cserni
Journal:  Pathol Oncol Res       Date:  1999       Impact factor: 3.201

Review 5.  Breast cancer (non-metastatic).

Authors:  Justin Stebbing; Geoff Delaney; Alastair Thompson
Journal:  BMJ Clin Evid       Date:  2011-02-08

6.  How do I deal with the axilla in patients with a positive sentinel lymph node?

Authors:  Conrad B Falkson
Journal:  Curr Treat Options Oncol       Date:  2011-12

7.  [Axillar lymphadenectomy].

Authors:  D Oertli
Journal:  Chirurg       Date:  2007-03       Impact factor: 0.955

Review 8.  Breast cancer (non-metastatic).

Authors:  Justin Stebbing; Geoff Delaney; Alistair Thompson
Journal:  BMJ Clin Evid       Date:  2007-12-04

9.  Axillary lymph node dissection in node-positive breast cancer: are ten nodes adequate and when is enough, enough?

Authors:  Laura H Rosenberger; Yi Ren; Samantha M Thomas; Rachel A Greenup; Oluwadamilola M Fayanju; E Shelley Hwang; Jennifer K Plichta
Journal:  Breast Cancer Res Treat       Date:  2019-11-18       Impact factor: 4.872

10.  Surgical Management of the Axilla in Elderly Women With Node-Positive Breast Cancer.

Authors:  Caitlin E Marks; Yi Ren; Laura H Rosenberger; Samantha M Thomas; Rachel A Greenup; Oluwadamilola M Fayanju; Susan McDuff; Gretchen Kimmick; E Shelley Hwang; Jennifer K Plichta
Journal:  J Surg Res       Date:  2020-05-29       Impact factor: 2.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.